Published in Biometals on January 07, 2009
The biosynthesis of nitrogen-, sulfur-, and high-carbon chain-containing sugars. Chem Soc Rev (2013) 1.14
A comprehensive review of glycosylated bacterial natural products. Chem Soc Rev (2015) 1.13
Targeting iron assimilation to develop new antibacterials. Expert Opin Drug Discov (2012) 0.97
Catecholate siderophores protect bacteria from pyochelin toxicity. PLoS One (2012) 0.95
Biosynthesis of albomycin δ(2) provides a template for assembling siderophore and aminoacyl-tRNA synthetase inhibitor conjugates. ACS Chem Biol (2012) 0.95
Beyond iron: non-classical biological functions of bacterial siderophores. Dalton Trans (2015) 0.94
FhuA (TonA), the career of a protein. J Bacteriol (2009) 0.90
Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. J Med Chem (2013) 0.87
The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics. J Bacteriol (2015) 0.86
Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers. Bioorg Med Chem (2012) 0.86
Enterobactin-mediated delivery of β-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli. J Am Chem Soc (2014) 0.84
Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus. Bioconjug Chem (2013) 0.82
Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wall. PLoS One (2010) 0.80
Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes. Antimicrob Agents Chemother (2015) 0.79
Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies. Microbiology (2015) 0.79
An update on iron acquisition by Legionella pneumophila: new pathways for siderophore uptake and ferric iron reduction. Future Microbiol (2015) 0.77
Syntheses of Siderophore-Drug Conjugates Using a Convergent Thiol-Maleimide System. ACS Med Chem Lett (2012) 0.77
A Branch Point of Streptomyces Sulfur Amino Acid Metabolism Controls the Production of Albomycin. Appl Environ Microbiol (2015) 0.75
A New Way to Beat Intestinal Pathogens. Trends Microbiol (2017) 0.75
Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic Biol Med (2016) 0.75
Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev (2008) 5.97
Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev (2007) 4.87
Structure and mechanism of ABC transporter proteins. Curr Opin Struct Biol (2007) 3.79
Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J Bacteriol (2008) 2.47
Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins. Antimicrob Agents Chemother (1988) 2.36
Ton-dependent colicins and microcins: modular design and evolution. Biochimie (2002) 1.95
Structural biology of bacterial iron uptake. Biochim Biophys Acta (2007) 1.90
Protonmotive force, ExbB and ligand-bound FepA drive conformational changes in TonB. Mol Microbiol (1999) 1.86
Nucleotide sequence of the colicin B activity gene cba: consensus pentapeptide among TonB-dependent colicins and receptors. J Bacteriol (1987) 1.79
Evolutionary relationship of uptake systems for biopolymers in Escherichia coli: cross-complementation between the TonB-ExbB-ExbD and the TolA-TolQ-TolR proteins. Mol Microbiol (1993) 1.72
Mode of action of GR69153, a novel catechol-substituted cephalosporin, and its interaction with the tonB-dependent iron transport system. Antimicrob Agents Chemother (1990) 1.72
Heme acquisition by hemophores. Biometals (2007) 1.72
E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system. Antimicrob Agents Chemother (1987) 1.66
TonB-dependent outer membrane transport: going for Baroque? Curr Opin Struct Biol (2005) 1.65
Iron acquisition in Vibrio cholerae. Biometals (2007) 1.50
Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter. Infect Immun (2002) 1.48
Uptake and conversion of the antibiotic albomycin by Escherichia coli K-12. Eur J Biochem (1979) 1.46
Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium. J Bacteriol (1983) 1.34
Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus. J Bacteriol (2001) 1.29
Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA. Protein Sci (2000) 1.27
Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity. J Biol Chem (2004) 1.27
Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates. Chem Biol (1996) 1.19
Novel whole-cell antibiotic biosensors for compound discovery. Appl Environ Microbiol (2007) 1.17
Metal trafficking via siderophores in Gram-negative bacteria: specificities and characteristics of the pyoverdine pathway. J Inorg Biochem (2007) 1.14
Ferrichrome transport in Escherichia coli K-12: altered substrate specificity of mutated periplasmic FhuD and interaction of FhuD with the integral membrane protein FhuB. J Bacteriol (1995) 1.11
The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus. Demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport. J Biol Chem (2003) 1.08
Highly efficient uptake of a rifamycin derivative via the FhuA-TonB-dependent uptake route in Escherichia coli. J Gen Microbiol (1987) 1.06
A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces species. J Antibiot (Tokyo) (2000) 1.05
Albomycin uptake via a ferric hydroxamate transport system of Streptococcus pneumoniae R6. J Bacteriol (2006) 1.04
Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA. Structure (2001) 1.04
Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter. J Bacteriol (2006) 1.03
Point mutations in two conserved glycine residues within the integral membrane protein FhuB affect iron(III) hydroxamate transport. Mol Gen Genet (1992) 0.96
Molecular dynamics simulations of the periplasmic ferric-hydroxamate binding protein FhuD. Biometals (2005) 0.93
Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae. Int J Med Microbiol (2007) 0.93
Active transport of siderophore-mimicking antibacterials across the outer membrane. Drug Resist Updat (1999) 0.91
Iron(III) hydroxamate transport in Escherichia coli K-12: FhuB-mediated membrane association of the FhuC protein and negative complementation of fhuC mutants. J Bacteriol (1992) 0.85
Transmembrane topology of the two FhuB domains representing the hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and vitamin B12. Microbiology (1998) 0.83
Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell (2003) 3.68
Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe (2010) 2.64
Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol (2007) 1.99
Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology (2003) 1.53
Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology (2007) 1.29
Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog (2009) 1.16
A C Symmetric Nitrate Complex with a Thiophene-Based Tripodal Receptor. Cryst Growth Des (2011) 1.14
Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cell Microbiol (2006) 1.14
ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions. Mol Cell Biol (2007) 1.12
The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep (2006) 1.10
Anion Cluster: Assembly of Dihydrogen Phosphates for the Formation of a Cyclic Anion Octamer. Cryst Growth Des (2012) 1.09
Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels. BMC Immunol (2008) 1.07
BK channels in innate immune functions of neutrophils and macrophages. Blood (2008) 1.07
Yersinia enterocolitica adhesin A induces production of interleukin-8 in epithelial cells. Infect Immun (2004) 1.04
The impact of erythrocyte age on eryptosis. Br J Haematol (2012) 1.00
Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int J Med Microbiol (2003) 0.98
Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm Bowel Dis (2007) 0.97
Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell Microbiol (2003) 0.95
Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner. Int J Med Microbiol (2007) 0.94
Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells. Bioconjug Chem (2015) 0.94
Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae. Int J Med Microbiol (2007) 0.93
Yersinia YopP-induced apoptotic cell death in murine dendritic cells is partially independent from action of caspases and exhibits necrosis-like features. Apoptosis (2006) 0.92
A self-assembled fluoride-water cyclic cluster of [F(H2O)]4(4-) in a molecular box. J Am Chem Soc (2012) 0.92
Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest (2015) 0.91
Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells. Int J Med Microbiol (2007) 0.89
Yersinia enterocolitica induces epithelial barrier dysfunction through regional tight junction changes in colonic HT-29/B6 cell monolayers. Lab Invest (2010) 0.89
IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock. J Immunol (2013) 0.88
Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors. Cell Physiol Biochem (2013) 0.86
Isotopic response of graft versus host disease following herpes zoster infection: case report and review of the literature. Acta Derm Venereol (2012) 0.86
Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo. PLoS Pathog (2010) 0.85
Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6. Eur J Immunol (2006) 0.85
Tris{2-[(3-thien-yl)methyl-idene-amino]-eth-yl}amine. Acta Crystallogr Sect E Struct Rep Online (2010) 0.85
Intercellular communication by related bacterial protein toxins: colicins, contact-dependent inhibitors, and proteins exported by the type VI secretion system. FEMS Microbiol Lett (2013) 0.85
Alternative approaches to antifungal therapies. Exp Dermatol (2012) 0.85
Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice. BMC Microbiol (2008) 0.84
Attenuated Yersinia enterocolitica mutant strains exhibit differential virulence in cytokine-deficient mice: implications for the development of novel live carrier vaccines. Infect Immun (2003) 0.84
Nanoscopic optical rulers beyond the FRET distance limit: fundamentals and applications. Chem Soc Rev (2014) 0.83
A quinoline based bis-urea receptor for anions: a selective receptor for hydrogen sulfate. Nat Prod Commun (2012) 0.83
Y. enterocolitica inhibits antigen degradation in dendritic cells. Microbes Infect (2008) 0.82
Rifampicin induces MDR1 expression in Candida albicans. J Antimicrob Chemother (2008) 0.82
Self-assembly of ordered water tetramers in an encapsulated [Br(H2O)12]- complex. Chem Commun (Camb) (2012) 0.82
Lipopeptides in the triggering of erythrocyte cell membrane scrambling. Cell Physiol Biochem (2008) 0.79
Yersinia enterocolitica YopT and Clostridium difficile toxin B induce expression of GILZ in epithelial cells. PLoS One (2012) 0.79
Increased susceptibility to Yersinia enterocolitica Infection of Tff2 deficient mice. Cell Physiol Biochem (2012) 0.77
Phosphate binding with a thiophene-based azamacrocycle in water. Inorg Chem Commun (2012) 0.77
Aptamer-conjugated theranostic hybrid graphene oxide with highly selective biosensing and combined therapy capability. Faraday Discuss (2014) 0.77
3,3'-Bis(quinolin-8-yl)-1,1'-[4,4'-methyl-enebis(4,1-phenyl-ene)]diurea. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction. J Innate Immun (2016) 0.75
Novel metal-organic framework with tunable fluorescence property: supramolecular signaling platform for polynitrophenolics. Dalton Trans (2015) 0.75